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The initial wave of conception and production of animal and human vaccines culminating 
with the human usage of vaccine against rabies (1885), supervised by Louis Pasteur (1822-
1895), although considered a great achievement in France, had met with several theoretical, 
methodological and technical weaknesses that threatened the reproducibility of the results as 
well as part of the validity of the approach. The problems were pointed out mostly by German 
scientists, but by French critics of Pasteur’s action as well. At first, problems were denied but 
answers to them were progressively brought in, years often after the first announcement of a 
success, according to a strategy that could be considered a kind of a posteriori re-construction 
of data that could have led to the initial positive conclusions. Such a progressive construction 
of acceptable practices, participate in a muddled attitude concerning the methodology used on 
medical issues during the period that Mirko Grmek has named the “heroic age” of the Institut 
Pasteur1. An entirely different scientific attitude, now involving quality control, quantification 
at every step of a production process, closer contacts with medical structures and a more 
positive attitude towards German science, was by contrast obvious at the beginning of the 
1890s. The development of serotherapy as a specific treatment of diphtheria, is the earliest 
example of that change: it involved the introduction of quantification and norms largely 
adapted from German procedures and which were approximate in earlier Pasteur’s protocols. 
It ultimately led to the building up of an Institut Pasteur - associated bio-industry that could 
compete with the German one.  
The present paper thus primarily deals with the manner a “culture of quantification and 
standardization” has been introduced at the Institut Pasteur or, more precisely, has been 
imposed by Emile Roux (1853-1933) and his co-workers, as part of Roux’s general project on 
the approach to infectious diseases, based on the direct coupling of research in microbiology 
to the production of drugs of biological or chemical origin by the institute, and to medical care 
in Pasteur’s hospital located on the campus itself.  
 
The weaknesses of Pasteur’s approach to vaccination were known of his fellow scientists. 
 
The distinctive place occupied by Pasteur in the scientific landscape of the French Third 
Republic has largely been described elsewhere2, as have been the conditions and uncertainties 
of Pasteur’s approach to vaccination, following the unveiling of Pasteur’s laboratory notes in 
19713. The present paper focuses on the evolution of laboratory practices at the Institut 
Pasteur during the 10 years that followed its creation in 1887, as it appears to reflect a 
deliberate strategy of French researchers to narrow the gap existing between Pasteur’s 
statements and Koch’s methods. The Koch-Pasteur dispute has been extensively discussed 
elsewhere4, and it can here be assumed that Koch’s arraignment of Pasteur’s approach to 
vaccination should primarily be considered as the enunciation of rules of good laboratory 
practices and methods in microbiology, thus a methodological discussion the benefit of which 
had been somehow obscured in France by the violence of the exchanges, by hagiography and 
nationalism. It has however been perceived as such by foreign scientists as well as by 
scientists around Pasteur5.  
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A short discussion of the anthrax and rabies cases can help defining the scientific problems as 
these have been expressed. The etiological agent of anthrax6 had been characterized by Robert 
Koch (1843-1910) in 1877, cause of a conflict with Pasteur on priority of discoveries7. 
Several “vaccines” against the disease had been tested in France before 1880, with no clear-
cut evidence that effective protection could be achieved. The results of the vaccination of 
sheep against anthrax obtained by injecting animals with oxygen-attenuated anthrax bacilli 
were first communicated on February 28, 18818. The experiment was publicly repeated on 
sheep in May 1881 at Pouilly-le-Fort and its results were highly publicized in France as a 
success-story. However experiments carried out in 1881-1882 in Germany met with no 
success and German scientists particularly Koch and Friedrich Loeffler (1852-1915) remained 
more than sceptical about the efficacy of Pasteur’s vaccine and its conception. Aside 
emotional and nationalistic comments in France and in Germany, several scientific criticisms 
were enunciated. It was pointed out that the observed protection might have merely been non-
specific, thus addressing the question of specificity of the protection, if any. Other criticisms 
were elicited by the irreproducibility of the results of vaccination. The initial oxygen-based 
attenuation process did not reproducibly inactivate the bacilli. Moreover, the protocol for 
attenuation of the anthrax bacilli used in the Pouilly-le-Fort experiment was published as late 
as in 1883. A chemically induced attenuation procedure previously rejected by Pasteur but 
used by Chamberland and Roux had been used without saying; the conditions for the 
substitution of techniques were rendered public only 50 years later9. Finally, the statistical 
analysis of the results was merely based on the comparison of large numbers, letality in the 
absence of vaccination being only a rough estimate. Actually, several years10 of work using 
Chamberland’s attenuated vaccine enabled Institut Pasteur’s researchers11 to collect a large 
enough number of cases to conclude at the International Congress of Hygiene in Vienna 
in1887 that cattle was protected against anthrax by vaccination to a level of 80-90%12. In 
summary, and irrespective of the fact that complete protection against anthrax is still 
nowadays more difficult to obtain than claimed in the1880s, doubts concerning Pasteur’s 
vaccine were due to uncertainties about the quality and the protocol for preparation of the 
reagent, premature release of significantly “positive” data and insufficient statistical 
discussion of the results. Co-workers of Pasteur were at least aware of the first two of these 
problems. 
Similar methodological problems emerge out of the rabies case13. A critical discussion of the 
conditions of preparation of the successive anti-rabies vaccines and the conditions of their 
first use on humans in 1885 has been extensively reported elsewhere14. Despite, the opposition 
of Roux to a premature extension to humans of the experiment, despite an immediate 
controversy in France on the effectiveness and danger of anti-rabies vaccination, the outcome 
of the first injections to two badly bitten children were understood in 1885 as the defeat of the 
disease, a strong emotional move that led to the creation of the Institut Pasteur in 1887 and 
later on, of numerous other Pasteur Institutes elsewhere15, all primarily devoted to vaccination 
against rabies. However, the treatment did not always prove efficient against the disease. The 
occasional absence of efficiency was attributed to the vaccine being injected too late after 
infection or to the localization of bites on the body. Since 1885 the techniques of preparation 
of the “virus-vaccine” were modified several times; the protocols used to inject the drug were 
subjected to major changes (“intensive” vs. “normal” treatment). Finally, no statistical 
analysis could be carried out in the obvious absence of negative controls and the lack of data 
concerning propagation of rabies in humans. The summing up of “cured cases” was 
considered as the proof of vaccine effectiveness, as shown by the monthly description of 
treated cases in the Annales de l’Institut Pasteur. The weakness of the demonstration was 
evident enough that it needed to be addressed to and was so by N. Gamaleya, vice-head of the 
Bacteriological Institute of Odessa, the frequency of rabies being much higher in Russia than 
  
 3 
in France16. Thus the notion of success in humans was a kind of extrapolation of data obtained 
on genuinely vaccinated animals rather than a rigorous demonstration of the development of a 
protection in presumably infected humans17. As for anthrax, one could note a combination of 
uncertainty concerning the vaccine and its administration, the premature release as a success 
of a treatment on humans and the absence of a proper statistical analysis and comment of the 
treated cases, all problems that were tentatively answered by the empirical adjustment of 
procedures and reagents, without, however, bringing the definitive proof of the efficiency of 
the procedure in man. Of course, microbiology was under construction and the shift to 
immunology had not occurred yet18. The description of the host-microbes relationships and 
the proper methods of study, including the usage of animals, were far from the high rationality 
prevailing in physiology19. Statistical analysis of results was far from being widespread. The 
lack of precision described above could thus have merely been a feature of a discipline 
emerging from a kind of chaos of observations and results. Whatever it had been due to, the 
restrictive or protective attitude of Chamberland, Roux and Duclaux strongly suggests they 
were aware of the problems from the beginning, though they never publicly interfered with 
Pasteur’s approach of vaccination and with his emotional ways of communicating with the 
public20. Would any doubt be left about the awareness of scientists around Pasteur, the 
scientific policy prevailing immediately after the creation of the Institut Pasteur and the near 
retirement of Pasteur, is so sharply contrasting that it implies that the above-mentioned 
weaknesses had been identified as serious enough to threaten scientific, medical and 
economical developments, particularly faced to research carried out by Institut Pasteur’s main 
competitor, Koch’s Institute of Hygiene in Berlin.  
 
A new environment for French microbiology 
 
The building of the Institut Pasteur has been financed by a public subscription launched by the 
French Academy of Medicine in 1886 and aimed at creating a rabies research and care centre. 
The Institut Pasteur inaugurated in 1888 actually obeyed a different project and was much 
more of an institute of general microbiology, with at most one-sixth of its surface devoted to 
rabies consultation and vaccination. The rest of the buildings, excepting a kennel located in 
the animal facilities (hôpital des animaux), was attributed to research in general microbiology 
and to teaching. It was distributed into several well identified laboratories each headed by a 
senior scientists21. From the very beginning of Institut Pasteur’s history, Roux has been in 
charge of defining plans with the architects and supervising the construction. Escaping the 
original devolution of the building to rabies studies, Roux designed the institute so that the 
different aspects of microbiology could be dealt with within the same building (the present 
batiment historique). Actually, Pasteur’s declining health had forced him to gradually resign 
after 1887 from his official positions and pushed Roux, who was 35 years old in 1888, 
towards leading intellectual and administrative positions within the Institut Pasteur22. It is 
difficult to ascertain why Roux was distinguished among others, particularly since he had 
opposed Pasteur by considering premature the experimentation on humans of the rabies 
vaccine.  Rabies was the only place of the institute where medicine was practiced, rabies 
consultation being set apart from the mainstream of research: Jacques-Joseph Grancher (1843-
1907), Chef de service at the Hôpital des Enfants-malades (a Paris hospital located in the 
vicinity of Institut Pasteur) a highly praised physician specialized in infectious diseases 
particularly diphtheria and tuberculosis was in charge of rabies consultation and ensured a 
link with hospital medicine and hygiene.  
The plans and the organization of the institute reflect the major change that had occurred in 
the manner research was conducted around Pasteur. Before the years 1887-1888, research was 
carried out in Pasteur’s own laboratories and facilities at the Ecole Normale Supérieure under 
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his close personal supervision, or at the veterinary school of Maisons-Alfort where Nocard 
had established a kind of branch of Pasteur’s laboratory.  The hierarchical structure was rather 
rigid. In contrast, from 1888 onwards, laboratory space was nominally allocated to heads of 
laboratories, the publications of which indicate they have become scientifically independent. 
They were all rather young: Roux was 35, Chamberland 36, Metchnikoff 42, Grancher 44; 
Yersin, the youngest, was 24 and Duclaux, the oldest, was 47. Duclaux was elected Director 
of the institute in 1895, after Pasteur’s death, but Roux and Metchnikoff clearly were the 
scientific leaders. The new team leaders were all civilians and have an open attitude towards 
European, particularly German, science. Roux, a former army physician who had left the 
army for insubordination, brought medical thinking into a research that he conducted with a 
rigorous approach to science, including technological developments (photography, 
temperature controlled incubators etc). Metchnikoff, a zoologist of Ukrainian origin, had long 
stayed in several European laboratories (1864-1866 in Germany: Heligoland with Kohn, 
Giessen with Leuckart; 1867 in Naples with Kovalevsky; then  from 1869 to 1873 in several 
marine laboratories in France, Spain and Italy in addition to Russia, which he left in 1888). 
Metchnikoff brought in a wealth of knowledge on diverse biological systems, including the 
invertebrates defense system against microbes. Yersin had first studied medicine in Marburg 
and attended Koch’s lessons in Berlin in 1889. Emile Duclaux (1840-1904) a chemist 
specialist of fermentations, teached biological chemistry at the Sorbonne and offered the link 
with the university. Chamberland, a physician and biologist close associate of Pasteur on the 
anthrax issue, was familiar enough with German science to be sent to Germany in 1887 to 
discuss results with Koch and Loeffler23. A number of non-permanent members of the Institut 
Pasteur worked in the laboratories or attended the cours de microbie technique given by Roux 
since 1889, and comprised numerous foreigners including Germans. In a few years, the 
Institut Pasteur had become a kind of interdisciplinary and international research centre.  
In general, the years 1880 have in many fields seen a turn towards less tense relations between 
France and Germany. On the science side, missions to study the functioning of German 
universities, initiated by chemists before the Franco-Prussian war, had resumed since 1877 
and their reports, for example on chemistry or embryology were published and widely 
discussed in the context of the reform of French universities24. It was assumed that France had 
been defeated by German science and technology and as a matter of consequence, German 
universities were considered as models for the strengthening of French university research 
and teaching and ultimately for revenge. Reports were most often enthusiastic about the level 
of the teaching, the organization of faculties and the relations between professors and 
students. Concerning researchers in microbiology at the Institut Pasteur the attitude of Pasteur 
engaged in conservative political circles and strongly anti-German, contrasts with that of most 
other scientists working with him. Part of the change in the attitudes may have been 
associated with the political beliefs of scientific leaders. As seen from official statements and 
from personal letters, none of them showed any particular chauvinistic attitude. Roux and 
Behring were friends and Roux and Metchnikoff were the godfathers of a Behring’s son. 
Letters exchanged between Roux and Metchnikoff and between Roux, Behring and 
Metchnikoff, indicate that Roux and Metchnikoff were highly confident in Koch’s scientific 
knowledge and competence. Metchnikoff and Yersin even submitted to him data or 
preparations in order to obtain confirmation of some of their most important results, though 
the two of them were rather ironic concerning the absence of personal opinion of scientists 
gathered around Koch25.  Most of Institut Pasteur’s researchers were politically close to 
socialists or radicals. Roux defended Dreyfus. Duclaux was more of a pacifist, very sensitive 
to human rights problems. He also defended Dreyfus as early as 1898 and contributed to the 
creation of “La ligue des droits de l’homme”. Chamberland had been elected Deputy to the 
parliament in 1885 and belonged to the républicain radical group and was active in defending 
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laws on public hygiene at the parliament, as did Grancher who belong to the same political 
party. Metchnikoff was a convinced socialist and pacifist, later a theosophist and had 
experienced serious problems with the tsarist administration in Odessa. Thus the scientific 
staff of the Institut Pasteur dominantly belang to the republican meritocracy of the Third 
Republic impregnated with social-democrat thinking and more open to foreign influences. 
The translation effort of foreign scientific publications was by no means new at the end of the 
years 1880, but the specific effort made by the Institut Pasteur in the follow up of foreign 
science is shown by the excellent coverage of foreign publications in the the Annales de 
l’Institut Pasteur launched in 1887 by Emile Duclaux (1840-1904)26. Although the rationale 
underlying the creation of the journal had clearly to deal with rivalry with Koch’s journal 
(Zeitschrift fur Hygiene und Infektionskrankheiten), with problems of priority and with the 
self-promotion of results obtained at the Institut Pasteur and related institutions27, the style of 
the papers was not polemical any longer and the Annales reported summaries of all works 
carried out elsewhere, particularly in Germany, that had looked important enough to the 
editors: microbiological information published in Germany was made readily available to 
French microbiologists28. Indeed, in their papers concerning diphtheria, Roux and his 
colleagues positively discussed the successive and decisive contribution of their German 
colleagues. As an example, the 1894 best known paper written by Roux and Louis Martin 
(1864-1946) and dealing with the preparation and testing of anti-diphtheria sera, was preceded 
by an extensive bibliography of papers published abroad and analysis of the articles by Emil 
von Behring (1854-1917), Shibasaburo Kitasato (1852-1931) and co-workers on the 
production of sera able to neutralize bacterial toxins. The authors acknowledged German 
contributions by plainly writing: Nous pouvons declarer que nos résultats confirment, dans ce 
qu’ils ont d’essentiel, ceux de M. Behring et de ses collaborateurs”29.  
In other words, the years 1885-1890 have seen the coming of Pasteur’s microbiologists out of 
the “heroic age”. Members of the staff of the Institut Pasteur had gained scientific and 
practical autonomy in the conduct of their work. Moreover, the work they carried out and the 
deliberations of the Board of administrators show that they were now conscious of the 
economical context and competition in which medical or veterinarian usage of biological 
derivatives was actually embedded30.  
 
Competition over antitoxins and usage of German standardization procedures 
 
Rabies has been a political more than a medical target for Pasteur31. In contrast with rabies, 
other human infectious diseases, tuberculosis, diphtheria, tetanus, syphilis etc, were genuine 
major public health problems in Western Europe and thereby attracted active research in 
France as in Germany. Despite early promising results, work on tetanus did not progress well 
and was rapidly slowed down for the benefit of diphtheria. The work carried out on diphtheria 
at the Institut Pasteur bears the hallmark of Roux’s personal approach. Actually, most of the 
work of Roux on diphtheria should be considered in a double context. Firstly, the context of a 
concurrence, a kind of a race with German scientists as pointed out by P. Weindling32: 
analysis of publications shows that very similar or complementary results were obtained and 
published by German and French scientists nearly at the same moment during the 
development of serotherapy. The work also developed in a way suggesting it was influenced 
by the will to avoid the criticisms raised against anti-anthrax and anti-rabies vaccines: the 
work and the results had to be impeccable particularly with respect to the German approach of 
the same problem(s). Secondly, Roux’ scientific strategy was underlaid by a rationalized 
medical project, proposed in 1894 as the conclusion of the successful trial on diphtheria and 
which resulted in 1900 in the construction of a dedicated hospital, the Hôpital de l’Institut 
Pasteur located on the Paris campus, in the vicinity of research laboratories33. To a certain 
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extent, the first twenty years of existence of the Institut Pasteur have been largely placed in 
the context of Roux’s medical project, which later extended far beyond diphtheria and soon 
included tropical diseases such as yellow fever, malaria and sleeping sickness as well as the 
test of their treatment 34. 
  
The causative agent of diphtheria is the Klebs-Loeffler bacillus (Corynebacterium 
diphtheriae), identified in 1883 in the throat lesions of patients. In the absence of treatment, 
diphtheria was in 1892-1894 responsible for an annual death toll of 6-7 per 10000 persons in 
Europe35. The suffocating form of diphtheria in children (named the “croup”) inspired much 
fear among parents. As for rabies, diphtheria was not only a deadly disease but also was a 
socially signified target for researchers36. Two main scientific breakthroughs have been made 
between 1885 and 1890 concerning the mechanisms of action of bacteria and of vaccines, 
respectively37. It has been shown that the microbial agents of diphtheria and tetanus acted 
through soluble toxins they release in the infected organisms; Behring and Kitasato have 
demonstrated that protective immunity could be induced against the toxins by injecting the 
latter into the proper recipient animals, a notion soon extended by Roux and co-workers to 
other soluble molecules. Behring and Erich Wernicke discovered that protection was 
associated with the serum of the immunized animals and transferable to other animals. 
Serotherapy is the development of that initial  and decisive discovery. The first period of 
research on diphtheria at the Institut Pasteur (1888-1889) corresponded to the verification by 
Roux 38 that the Klebs-Loeffler bacillus was the genuine cause of diphtheria and the 
demonstration that the symptoms of the disease could be reproduced by injecting animals with 
the poison secreted by in vitro grown bacteria. A year later, Roux and Alexandre Yersin 
(1853-1943) described some properties of the toxin39. As soon as Wernicke’s paper describing 
the cure of three diphtheria cases in children by injection of the sera of dogs that have 
survived toxin and bacteria injections, was known and discussed at the institute40, the 
preparation of hyper-immune sera in horses was initiated at the end of 1891 by Edmond 
Nocard (1850-1903) at the veterinary school of Maisons-Alfort41. From the fall of 1894, large 
scale serum production was organized mostly in the annexe of the Institut Pasteur in Marnes-
la-Coquette near Paris42. The first 1894 paper written by Roux and Martin deals with the 
preparation and test of the horse sera. The quality and protective features of serum produced 
in various animals had already been tested by German scientists, the dog serum initially used 
by Wernicke being a mere by-product of earlier experimental infection experiments. The 
choice of horses as serum producers suggested by German scientists was promptly verified in 
Paris: the choice of horses was the result of a compromise between the needs of large-scale 
production, the lowest spontaneous toxicity of sera, and the highest protective efficacy. In 
contrast with earlier articles on anthrax or rabies vaccines which were rather imprecise about 
the technical procedures used, the protocols concerning the isolation and inactivation of 
diphtheria toxin were extensively described making them reproducible elsewhere. 
Accordingly, the methods used to control the sequential steps leading to the selection and tests 
of serum by using in vivo assays on guinea pigs and rabbits, were fully described. The 
protocols of bacterial growth were adapted to the induction of the secretion of the toxin in the 
supernatant of long-term cultures. The toxicity of diphtheria toxin was defined in vivo as the 
volume of supernatant which kills a 500 g guinea pig in 48 hours. The chemical inactivation 
of the toxin using iodine trichloride was used and described. It was largely inspired by the 
disinfectants used by German army physicians during the Franco-Prussian war and 
systematically studied afterwards. Residual toxicity of inactivated diphtheria toxin was tested 
on rabbits. The protocol of injection in to horses of increasing doses of the inactivated toxin, 
then of pure toxin in order to prepare protective immune sera, was described in great detail: 
the health and behaviour of each injected horse was monitored in laboratory files43 and some 
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exemplary cases were reported in the paper, including immunization of a cow. More 
importantly, the anti-toxic properties of the sera of each individual horse were tested in vivo 
on a panel of guinea pigs challenged with a defined quantity of toxin, along with the 
appropriate negative and positive controls. This enabled the definition of protective units. The 
definition of the units used by Roux and Martin in 1894 (one ml of horse serum able to 
neutralize 20 ml of a toxin solution, 0.1ml of the latter killing a 500g guinea pig in 48 hours) 
was preceded by a one-page description of the three successive types of units used by Behring 
and Paul Ehrlich (1854-1915). The need for international units was emphasized: Roux 
speculated that standardization would be of more general use if comparative studies could be 
carried out using Behring’s toxin and sera44. Finally, the amount of serum to be administered 
to children was defined on a weight- (guinea pig) to-weight (child) basis. The entire 
production and test process thus obeyed a defined and published protocol. The units may have 
been different in France and Germany, the point is they were linked by a proportionality 
factor which made easy the comparison of their properties. Standardization of anti-diphtheria 
serum in France was definitively associated with the fact that German scientists had already 
worked out their own standards. Indeed, Roux wrote, A vrai dire, nous n’attachons pas 
beaucoup d’importance à toutes ces definitions compliquées (…) Cependant il était 
nécessaire de parler de ces unités de mesure, puisqu’elles sont employées à chaque instant 
dans les travaux allemands. Anyway, standardization of biological reagents became an 
integral part of Pasteurian culture as early as the beginning of 1894. The Direction of Hygiene 
of the Ministry of the Interior, in a note dated February 10, 1895, defined the conditions of 
delivery (20-ml vials) of the reagent by the Institut Pasteur and pharmacies, with no mention 
of other Institutions allowed to produce the serum. The 20 ml-dose was the dose injected by 
Martin into incoming patients prior to bacteriological diagnosis. It corresponded to the ability 
to neutralize 200ml of toxin supernatant in the in vivo guinea pig test45. The anti-diphtheria 
serum became a drug with standardized usage in France as of April, 25, 189546. 
 
A rational statistical analysis 
 
The second important step in the usage of a therapeutic reagent is the proper statistical 
analysis of the results obtained on humans. We mentioned in an earlier section that statistical 
analysis was one of the weaknesses of initial Pasteur’s tests of vaccines. Statistical analysis of 
results of therapeutic trials was not commonly used in medicine47 but the progressive 
assessment of the efficacy of serotherapy by introducing properly defined cohorts and 
controls has led in 1898 in Denmark to what Ian Chalmers named the first random trial in 
human medicine48. Concerning the definition of test cohorts, an important step took place in 
1890 with Roux’s decision to introduce systematic bacteriological diagnosis in patients 
suspected of having diphtheria: physicians were faced to difficulties in diagnosing true 
diphtheria because of the heterogeneity of the clinical signs shown by patients, thus leading to 
erroneous diagnoses. The introduction of bacteriological testing of diphtheria had two main 
consequences: one was clinical in nature, namely concerning prognosis and monitoring of the 
presence of the bacterium during the evolution of the disease, including during convalescence; 
the second was statistical in nature, allowing the sorting out of patients into better defined 
groups. The group of patients suffering from proven diphtheria was further subdivided into 
two groups, those with diphtheria bacilli alone and those with diphtheria bacilli associated 
with other pathogens, an association found to be of poor prognosis49. In modern statistical 
terms, this means that cases could be organized in cohorts defined on a bacteriological basis. 
Bacteriological diagnosis was carried out in a laboratory implemented in the Hôpital des 
Enfants-malades by Louis Martin (1864-1946), a physician selected by Roux among 
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Grancher’s students. The selection of groups among the large number of patients used to test 
serotherapy was based on bacteriological criteria50.  
The second 1894 article by Roux and Martin describes large-scale clinical trials of the 
previously defined anti-diphtheria sera51. There is no need to present once more the results 
communicated by Roux at the International Congress of Hygiene of Budapest in September 
1894, except by noting that priority had been granted by a preliminary communication given 
in Lille in spring 1894. At the same Budapest meeting, Hans Aronson of Berlin confirmed 
that identical results had been obtained in Germany on diphtheria patients, a communication 
showing that the stage of development of serotherapy was primarily the same in France and in 
Germany. The discussion that followed oral presentations showed a general consensus on the 
efficacy of the therapeutic method and pointed to the highly significance of the numbers that 
have been reported, treated vs. untreated patients52.  
 It may be retrospectively surprising to note that no participant openly reacted to some 
ambiguities of the study. Roux and Martin compared two cohorts of patients identically 
defined in terms of bacterial infections: members of the treated group received serum in 
Grancher’s own ward at the Hôpital des Enfants-malades in Paris, and the members of the 
second group, here used as a negative control, were hospitalised at the Hôpital Trousseau, 
East of Paris and did not receive any injection. However neither the patient population, nor 
the organisation of the hospital, the hygienic rules applied in the wards, the frequency of 
tracheotomy etc. were necessarily the same at Trousseau and at the Enfants-malades. 
Although intuitively suggestive of a several-fold decrease of the death toll in treated patients, 
the results could have been statistically less significant.  
Anyway, since the fall 1894, anti-diphtheria serum was largely distributed in Europe by 
French and German institutes. An overall 2-5-fold decrease in lethality counts was observed 
through most countries in Europe during the following two years and was attributed to the use 
of antiserum53, although the effects of new isolation rules in hospitals may have contributed to 
the decline of mortality. The adverse effects of serum-therapy (serum sickness) were known 
but barely questioned in France54. Accidents however soon limited the usage of the antiserum, 
by casting some shadow on the benefit of using it. The genuine positive effects of the sera on 
the outcome of the diseases in diphtheria patients were only proven later, in 1898, by a Danish 
physician of the Blegsdamhospitalet in Copenhagen, Johannes Fibinger (1867-1928). Fibiger 
wanted to determine if anti-diphtheria serum was worth using considering its serious side 
effects. He introduced a genuine random trial (same hospital, same diagnosis, one day 
incoming patients are treated, the other day incoming patients are not etc), used sera of Dane, 
German and French origin and then demonstrated the existence of a significant benefit for 
serum-treated patients thus confirming earlier conclusions55.  
Later on, proper statistical analysis of test results were of particular significance in the 
evaluation of the efficacy of several antisera and vaccines produced by the Institut Pasteur 
(against diphtheria, tetanus, typhoid, gangrene, typhus, staphylococci) and tested on the field 
during World War I by army physicians.  
 
State-defined norms of quality, or Pasteur-control of quality on French producers of 
antisera ?  
 
A fundamental question concerning the significance of the norms used in France stems from 
the condition of quasi-monopoly of production and trade of the antisera granted in France to 
the Institut Pasteur, a condition which contrasts with state-defined standardization procedures 
used in Germany. Put in other words, was the control of quality of the antiserum, the norms of 
which had been defined by Institut Pasteur before being confirmed by the Ministry of Interior, 
exerted by some independent supervisory office or institution? The serum committee of the 
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Academy of Medicine set up for that purpose in May 1895 by the health administration was 
largely controlled by influent members of the staff of the Institut Pasteur. It can be concluded 
that the Institut Pasteur was at the same time issuing norms and controlling the obedience to 
norms. It is beyond doubt that the Institut Pasteur occupied a privileged position in France 
concerning infectious diseases, and an original place in the French public health landscape56. 
However, the situation that prevailed before World War I was less of an official monopoly 
granted to the Institut than a kind of institutionalised tutorship of the Institut Pasteur onto 
other private and public health institutions. Also, with the exception of the original agreement 
granted by government agencies to drugs and reagents of therapeutic use against infectious 
diseases, the production and trade of the latter were left to the initiative of private structures 
and local administrations, provided their activity was approve by the above mentioned 
committee, thus indirectly by the Institut Pasteur.  In this respect, the Institut Pasteur had in 
general managed to place itself at critical places in the network of public health institutions 
organized as a response to the requests of different components of the French administration. 
As an example, the bacteriological diagnosis of diphtheria had to be carried out either at the 
Institut Pasteur or in trustworthy laboratories, such as that established in the Hôpital des 
Enfants-malades: this actually meant laboratories headed by people trained at the Institut 
Pasteur. This observation could in turn define the Cours de microbie technique created by 
Roux as early as 1888, not only as an original, high-level training course, but also as a 
powerful tool for the organization of a network of people and institutions associated in some 
way to the Institut Pasteur57.  
The production of anti-diphtheria serum was not co-ordinated at a national level or transferred 
to industry under the quality control of state agencies, even through delegation given to the 
Institut Pasteur. Production in Paris was made in response to local needs (Paris and 
surrounding areas). Dried serum could eventually be transported to more distant places in 
France and out of France, but local production of antiserum was preferred. However, that 
production remained under the supervision of the Institut Pasteur of Paris. In distant areas, the 
serum was produced under the supervision of people trained and approved by the Institut 
Pasteur on behalf of the committee. Several instituts sérothérapiques endowed with the 
production of serum, were created in France at the end of the 19th century (Marseille, 
Bordeaux, Rennes, Lyon etc.) and abroad, such as in Geneva58. Some, because of their name, 
are not easily identified as such. As an example, Institut Bouisson Bertrand was created in 
Montpellier on February 6, 1897 due to a purely private initiative. The Institut sérothérapique 
de Lille, re-named Institut Pasteur de Lille in 1898, was created by Albert Calmette (1863-
1933) to produce anti-diphtheria serum at the request of the municipality of Lille. Calmette 
was a well-known “Pasteurian” scientist who had created the Institut Pasteur of Saigon in 
189059. In that particular case the use of the name “Pasteur” was granted to an institution 
placed under the administrative rule of the city of Lille and the Nord department. The 
interesting, well-documented case of Nancy, illustrates the complexity of the production and 
trade of anti-diphtheria serum in France60. Nancy, a city to which the University of Strasbourg 
had settled after the Franco-Prussian war of 1870, had developed a strong tradition of hygiene 
and social care at the city level as well as teaching at the university.  Following the 1894 
meeting in Budapest, in a manner highly reminiscent of the national initiative of the 
newspaper Le Figaro, which had led to the creation of the annexe of the Institut Pasteur of in 
Marnes-la-Coquette, a regional subscription was launched by Pierre Parisot (1854-1938), a 
Professor of legal medicine at the University of Nancy, first to purchase serum from Paris, 
then to create a centre for its production and distribution. The serum obviously could have 
been purchased from nearby German factories. The initiative of creating a production centre 
in Nancy, Germany, may thus have been political as suggested by J. Simon61. It however 
appears to participate in a broader strategy which resulted in the creation of a number of 
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similar centres far from the German boundary and thus independent of nationalistic 
considerations. The Institut de sérothérapie de l’Est started producing anti-diphtheria serum 
in November 1894 by using toxin provided by Roux. Later, the toxin as well as the serum was 
produced locally and up to 100 horses could be immunized in 1900, providing serum to all 
departments of Eastern France. The new building of the Institut de sérothérapie de l’Est, 
Fondation Osiris, was located in Nancy’s general hospital and opened in June 1896. It was 
placed under the supervision of Eugène Macé (1856-1938), a microbiologist trained in 1894 
by Roux at the Institut Pasteur. The  conditions of the opening and the administrative situation 
of the Institut de sérothérapie de l’Est were complex62. It appears to have been a semi-public 
institution, subsidized by the municipality of Nancy and the department, administrated by the 
board of directors of the “Société privée de l’Institut sérothérapique de l’Est,” located in a 
general hospital and soon included in the Institut d‘Hygiène of the University and later placed 
under the scientific and medical control of professors at the Faculty of medicine. It is not clear 
at this time whether the very same biological criteria as in Paris were used to define the 
protective units of the sera produced in Nancy. For example, vials containing smaller volumes 
of serum (10 ml, no titre indicated) were delivered to pharmacists. Nancy is exemplary of the 
manner procedures were taught person to person to other physicians in Institut Pasteur’s 
laboratories and with the agreement of the local administration, rather than implemented 
under strict government rules or through industry and its controls. However effective may 
have been the initial control of the Institut Pasteur on the quality of the reagents and the 
training of people in charge of producing them, the multiplicity of the production and 
distribution centres is likely to have rendered difficult maintaining a strict standardization of 
the anti-toxic activity of the sera distributed throughout France and its colonies. 
 
Two conclusions can be brought out of the present survey of the introduction of norms at the 
Institut Pasteur as one of the consequences of the development of serotherapy. Firstly, less 
than five years had been required for all steps of production and clinical tests, to become 
standardized and included in a procedure endowed by the Institut Pasteur and transmitted to 
other French health institutions. A culture of standardization, a genuine breaking off earlier 
practices, was attained and persisted. The whole process had important consequences in the 
long term. Since the production of anti-diphtheria serum had been initiated in Marnes-la-
Coquette in the fall 1894, a dual scientific culture has developed at the Institut Pasteur. 
Fundamental research in microbiology and related disciplines remained carried out primarily 
at the Institut Pasteur in Paris proper. Research aimed at producing standardized 
pharmaceutical reagents was primarily carried out in the Marnes-la-Coquette annexe which 
started as a mere horse-stable in 1894 and ended as an integrated production centre for a 
variety of sera and vaccines, largely before WWI. This so-called “applied” research, the 
associated production of a variety of reagents, although remaining under the supervision of 
scientists working in Paris stricto sensu particularly through the service de sérothérapie 
headed by Roux since 1894, was locally dominated by veterinarians. Among them, Alexis 
Prévot (? -1926) and Gaston Ramon (1886-1963) were the most prominent figures. Despite 
the genuine technological and scientific importance of the results obtained in Marnes (such as 
the discovery of anatoxins and the assay of specific antitoxin antibodies by flocculation tests, 
both discovered by Ramon soon after WWI), also despite the highly positive financial 
consequences of these activities for the Institut Pasteur, research carried out in Marnes was 
largely though unofficially, considered as requiring inferior scientific aptitudes and skills. 
These two clear-cut cultural identities co-existed until the disappearance of Institut Pasteur 
Production in the early 1970s. Secondly, not considering the administrative context which 
will be dealt with elsewhere, standardization of the whole process of production of anti-
diphtheria serum needed the quantitative assessment of parameters and steps including the 
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characterization of the virulence of well-defined microbial strains, the  toxicity (of toxins and 
of immunization reagents), controlled attenuation of virulence and evaluation of protective 
effects of the sera. In this respect, the answers given to the various objections raised against 
the first wave of Pasteur’s vaccines have contributed to the construction of a step-wise, 
ordered approach to the production of therapeutic reagents. It has often been argued that the 
French merely had copied the Germans. Analysis of the laboratory practices rather shows a 
reciprocal usage of the data obtained on both sides, most probably made easier by a change in 
the attitude of scientists of the Institut Pasteur after 1887. The opposition between French and 
German scientists, aggressive during the “heroic age” of the Institut Pasteur, had indeed lost 
its acuteness after 1890 and in some instances, such as Roux, Metchnikoff, Behring and 
Pfeiffer the relations have reached a rather friendly stage. Although hostility may have 
remained rooted in some of the persons involved in the competition, the harsh discussions 
between German and French scientists significantly and positively contributed to improving 
the emerging concepts and practices of vaccination against infectious agents. The different 
steps in the production of efficient biological reagents were clearly individualized, and 
standards and controls were introduced at the proper levels more or less simultaneously in the 
two countries before merging through the use of Frankfort’s standards. The preparation and 
use of anti-diphtheria serum at the Institut Pasteur thus largely benefited from that 
“epistemology in progress” which finally resulted in the emergence at the Institut Pasteur, and 
particularly in the Service de sérothérapie, of a kind of culture of quantitative evaluation of 
therapeutic reagents and clinical trials, which must be opposed to the attitudes prevailing 
before. Although such a conclusion may appear provocative, although the way of conducting 
research particularly in the context of nascent medical microbiology was different in Koch-
Behring and in Roux-Duclaux laboratories, we suggest that the development, test and rapid 
diffusion of serum therapy against diphtheria in Europe are the consequences of reciprocal 
transfers of knowledge from a local context to another and vice-versa. The development of 
serum-therapy in France was not the mere mimicking or transplant of techniques and 
protocols set up in Germany, but rather a succession of adaptive moves. A very similar 
reciprocal transfer of knowledge between German and French laboratories has been studied 
on several other cases, immunology63 and therapeutic chemistry64 at the Institut Pasteur and 
experimental psychology at the Sorbonne65. The history of serum-therapy is thus to be 
replaced in the general context of the ambiguous and finally positive relations between French 
and German researchers and universities which developed soon after the 1870 war until 
WWI66 .  
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